TY - JOUR
T1 - A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes
T2 - The EPIC-InterAct case-cohort study
AU - Imamura, Fumiaki
AU - Sharp, Stephen J.
AU - Koulman, Albert
AU - Schulze, Matthias B.
AU - Kröger, Janine
AU - Griffin, Julian L.
AU - Huerta, José María
AU - Guevara, Marcela
AU - Sluijs, Ivonne
AU - Agudo, Antonio
AU - Ardanaz, Eva
AU - Balkau, Beverley
AU - Boeing, Heiner
AU - Chajes, Veronique
AU - Dahm, Christina C.
AU - Dow, Courtney
AU - Fagherazzi, Guy
AU - Feskens, Edith J.M.
AU - Franks, Paul W.
AU - Gavrila, Diana
AU - Gunter, Marc
AU - Kaaks, Rudolf
AU - Key, Timothy J.
AU - Khaw, Kay Tee
AU - Kühn, Tilman
AU - Melander, Olle
AU - Molina-Portillo, Elena
AU - Nilsson, Peter M.
AU - Olsen, Anja
AU - Overvad, Kim
AU - Palli, Domenico
AU - Panico, Salvatore
AU - Rolandsson, Olov
AU - Sieri, Sabina
AU - Sacerdote, Carlotta
AU - Slimani, Nadia
AU - Spijkerman, Annemieke M.W.
AU - Tjønneland, Anne
AU - Tumino, Rosario
AU - van der Schouw, Yvonne T.
AU - Langenberg, Claudia
AU - Riboli, Elio
AU - Forouhi, Nita G.
AU - Wareham, Nick J.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Background: Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. Methods and findings: We measured plasma phospholipid fatty acids by gas chromatography in 27,296 adults, including 12,132 incident cases of T2D, over the follow-up period between baseline (1991–1998) and 31 December 2007 in 8 European countries in EPIC-InterAct, a nested case-cohort study. The first principal component derived by principal component analysis of 27 individual fatty acids (mole percentage) was the main exposure (subsequently called the fatty acid pattern score [FA-pattern score]). The FA-pattern score was partly characterised by high concentrations of linoleic acid, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations of γ-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained 16.1% of the overall variability of the 27 fatty acids. Based on country-specific Prentice-weighted Cox regression and random-effects meta-analysis, the FA-pattern score was associated with lower incident T2D. Comparing the top to the bottom fifth of the score, the hazard ratio of incident T2D was 0.23 (95% CI 0.19–0.29) adjusted for potential confounders and 0.37 (95% CI 0.27–0.50) further adjusted for metabolic risk factors. The association changed little after adjustment for individual fatty acids or fatty acid subclasses. In cross-sectional analyses relating the FA-pattern score to metabolic, genetic, and dietary factors, the FA-pattern score was inversely associated with adiposity, triglycerides, liver enzymes, C-reactive protein, a genetic score representing insulin resistance, and dietary intakes of soft drinks and alcohol and was positively associated with high-density-lipoprotein cholesterol and intakes of polyunsaturated fat, dietary fibre, and coffee (p < 0.05 each). Limitations include potential measurement error in the fatty acids and other model covariates and possible residual confounding. Conclusions: A combination of individual fatty acids, characterised by high concentrations of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incidence of T2D. The specific fatty acid pattern may be influenced by metabolic, genetic, and dietary factors.
AB - Background: Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. Methods and findings: We measured plasma phospholipid fatty acids by gas chromatography in 27,296 adults, including 12,132 incident cases of T2D, over the follow-up period between baseline (1991–1998) and 31 December 2007 in 8 European countries in EPIC-InterAct, a nested case-cohort study. The first principal component derived by principal component analysis of 27 individual fatty acids (mole percentage) was the main exposure (subsequently called the fatty acid pattern score [FA-pattern score]). The FA-pattern score was partly characterised by high concentrations of linoleic acid, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations of γ-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained 16.1% of the overall variability of the 27 fatty acids. Based on country-specific Prentice-weighted Cox regression and random-effects meta-analysis, the FA-pattern score was associated with lower incident T2D. Comparing the top to the bottom fifth of the score, the hazard ratio of incident T2D was 0.23 (95% CI 0.19–0.29) adjusted for potential confounders and 0.37 (95% CI 0.27–0.50) further adjusted for metabolic risk factors. The association changed little after adjustment for individual fatty acids or fatty acid subclasses. In cross-sectional analyses relating the FA-pattern score to metabolic, genetic, and dietary factors, the FA-pattern score was inversely associated with adiposity, triglycerides, liver enzymes, C-reactive protein, a genetic score representing insulin resistance, and dietary intakes of soft drinks and alcohol and was positively associated with high-density-lipoprotein cholesterol and intakes of polyunsaturated fat, dietary fibre, and coffee (p < 0.05 each). Limitations include potential measurement error in the fatty acids and other model covariates and possible residual confounding. Conclusions: A combination of individual fatty acids, characterised by high concentrations of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incidence of T2D. The specific fatty acid pattern may be influenced by metabolic, genetic, and dietary factors.
UR - http://www.scopus.com/inward/record.url?scp=85031815217&partnerID=8YFLogxK
U2 - 10.1371/journal.pmed.1002409
DO - 10.1371/journal.pmed.1002409
M3 - Article
C2 - 29020051
AN - SCOPUS:85031815217
SN - 1549-1277
VL - 14
JO - PLoS Medicine
JF - PLoS Medicine
IS - 10
M1 - e1002409
ER -